Increased lipogenic capacity of the islets of obese rats: A role in the pathogenesls of NIDDM

Young H Lee, Hiroshi Hirose, Yan Ting Zhou, Victoria Esser, J. Denis McGarry, Roger H Unger

Research output: Contribution to journalArticle

172 Citations (Scopus)

Abstract

The onset of NIDDM in obese Zucker diabetic fatty (fa/fa) rats is preceded by a striking increase in the plasma levels of free fatty acids (FFAs) and by a sixfold rise in triglyceride content in the pancreatic islets. The latter finding provides clear evidence of elevated tissue levels of long-chain fatty acyl CoA, which can impair β-cell cell function. To determine if the triglyceride accumulation is entirely the passive consequence of high plasma FFA levels or if prediabetic islets have an increased lipogenic capacity that might predispose to NIDDM, the metabolism of long-chain fatty acids was compared in islets of obese prediabetic and nonprediabetic Zucker diabetic fatty (ZDF) rats and of lean Wistar and lean ZDF rats. When cultured in 1 or 2 mmol/l FFA, islets of both female and male obese rats accumulated, respectively, 7 and 15 times as much triglyceride as islets from lean rats exposed to identical FFA concentrations. The esterification of [14C]palmitate and 9,10-[3H]palmitate was increased in islets of male obese rats and could not be accounted for by defective oxidation of 9,10-[3H]-palmitate. Glycerol-3-PO4 acyltransferase (GPAT) activity was 12 times that of controls. The mRNA of GPAT was increased in islets of obese rats. We conclude that, in the presence of comparable elevations in FFA concentrations, the islets of obese prediabetic rats have a higher lipogenic capacity than controls. This could be a factor in their high risk of diabetes.

Original languageEnglish (US)
Pages (from-to)408-413
Number of pages6
JournalDiabetes
Volume46
Issue number3
StatePublished - Mar 1997

Fingerprint

Type 2 Diabetes Mellitus
Nonesterified Fatty Acids
Palmitates
Acyltransferases
Acyl Coenzyme A
Triglycerides
Glycerol
Esterification
Islets of Langerhans
Wistar Rats
Fatty Acids
Messenger RNA

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Increased lipogenic capacity of the islets of obese rats : A role in the pathogenesls of NIDDM. / Lee, Young H; Hirose, Hiroshi; Zhou, Yan Ting; Esser, Victoria; McGarry, J. Denis; Unger, Roger H.

In: Diabetes, Vol. 46, No. 3, 03.1997, p. 408-413.

Research output: Contribution to journalArticle

Lee, YH, Hirose, H, Zhou, YT, Esser, V, McGarry, JD & Unger, RH 1997, 'Increased lipogenic capacity of the islets of obese rats: A role in the pathogenesls of NIDDM', Diabetes, vol. 46, no. 3, pp. 408-413.
Lee, Young H ; Hirose, Hiroshi ; Zhou, Yan Ting ; Esser, Victoria ; McGarry, J. Denis ; Unger, Roger H. / Increased lipogenic capacity of the islets of obese rats : A role in the pathogenesls of NIDDM. In: Diabetes. 1997 ; Vol. 46, No. 3. pp. 408-413.
@article{dbf9639a5b7b4f929ef26fdd516e2ed8,
title = "Increased lipogenic capacity of the islets of obese rats: A role in the pathogenesls of NIDDM",
abstract = "The onset of NIDDM in obese Zucker diabetic fatty (fa/fa) rats is preceded by a striking increase in the plasma levels of free fatty acids (FFAs) and by a sixfold rise in triglyceride content in the pancreatic islets. The latter finding provides clear evidence of elevated tissue levels of long-chain fatty acyl CoA, which can impair β-cell cell function. To determine if the triglyceride accumulation is entirely the passive consequence of high plasma FFA levels or if prediabetic islets have an increased lipogenic capacity that might predispose to NIDDM, the metabolism of long-chain fatty acids was compared in islets of obese prediabetic and nonprediabetic Zucker diabetic fatty (ZDF) rats and of lean Wistar and lean ZDF rats. When cultured in 1 or 2 mmol/l FFA, islets of both female and male obese rats accumulated, respectively, 7 and 15 times as much triglyceride as islets from lean rats exposed to identical FFA concentrations. The esterification of [14C]palmitate and 9,10-[3H]palmitate was increased in islets of male obese rats and could not be accounted for by defective oxidation of 9,10-[3H]-palmitate. Glycerol-3-PO4 acyltransferase (GPAT) activity was 12 times that of controls. The mRNA of GPAT was increased in islets of obese rats. We conclude that, in the presence of comparable elevations in FFA concentrations, the islets of obese prediabetic rats have a higher lipogenic capacity than controls. This could be a factor in their high risk of diabetes.",
author = "Lee, {Young H} and Hiroshi Hirose and Zhou, {Yan Ting} and Victoria Esser and McGarry, {J. Denis} and Unger, {Roger H}",
year = "1997",
month = "3",
language = "English (US)",
volume = "46",
pages = "408--413",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "3",

}

TY - JOUR

T1 - Increased lipogenic capacity of the islets of obese rats

T2 - A role in the pathogenesls of NIDDM

AU - Lee, Young H

AU - Hirose, Hiroshi

AU - Zhou, Yan Ting

AU - Esser, Victoria

AU - McGarry, J. Denis

AU - Unger, Roger H

PY - 1997/3

Y1 - 1997/3

N2 - The onset of NIDDM in obese Zucker diabetic fatty (fa/fa) rats is preceded by a striking increase in the plasma levels of free fatty acids (FFAs) and by a sixfold rise in triglyceride content in the pancreatic islets. The latter finding provides clear evidence of elevated tissue levels of long-chain fatty acyl CoA, which can impair β-cell cell function. To determine if the triglyceride accumulation is entirely the passive consequence of high plasma FFA levels or if prediabetic islets have an increased lipogenic capacity that might predispose to NIDDM, the metabolism of long-chain fatty acids was compared in islets of obese prediabetic and nonprediabetic Zucker diabetic fatty (ZDF) rats and of lean Wistar and lean ZDF rats. When cultured in 1 or 2 mmol/l FFA, islets of both female and male obese rats accumulated, respectively, 7 and 15 times as much triglyceride as islets from lean rats exposed to identical FFA concentrations. The esterification of [14C]palmitate and 9,10-[3H]palmitate was increased in islets of male obese rats and could not be accounted for by defective oxidation of 9,10-[3H]-palmitate. Glycerol-3-PO4 acyltransferase (GPAT) activity was 12 times that of controls. The mRNA of GPAT was increased in islets of obese rats. We conclude that, in the presence of comparable elevations in FFA concentrations, the islets of obese prediabetic rats have a higher lipogenic capacity than controls. This could be a factor in their high risk of diabetes.

AB - The onset of NIDDM in obese Zucker diabetic fatty (fa/fa) rats is preceded by a striking increase in the plasma levels of free fatty acids (FFAs) and by a sixfold rise in triglyceride content in the pancreatic islets. The latter finding provides clear evidence of elevated tissue levels of long-chain fatty acyl CoA, which can impair β-cell cell function. To determine if the triglyceride accumulation is entirely the passive consequence of high plasma FFA levels or if prediabetic islets have an increased lipogenic capacity that might predispose to NIDDM, the metabolism of long-chain fatty acids was compared in islets of obese prediabetic and nonprediabetic Zucker diabetic fatty (ZDF) rats and of lean Wistar and lean ZDF rats. When cultured in 1 or 2 mmol/l FFA, islets of both female and male obese rats accumulated, respectively, 7 and 15 times as much triglyceride as islets from lean rats exposed to identical FFA concentrations. The esterification of [14C]palmitate and 9,10-[3H]palmitate was increased in islets of male obese rats and could not be accounted for by defective oxidation of 9,10-[3H]-palmitate. Glycerol-3-PO4 acyltransferase (GPAT) activity was 12 times that of controls. The mRNA of GPAT was increased in islets of obese rats. We conclude that, in the presence of comparable elevations in FFA concentrations, the islets of obese prediabetic rats have a higher lipogenic capacity than controls. This could be a factor in their high risk of diabetes.

UR - http://www.scopus.com/inward/record.url?scp=0031048115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031048115&partnerID=8YFLogxK

M3 - Article

C2 - 9032096

AN - SCOPUS:0031048115

VL - 46

SP - 408

EP - 413

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 3

ER -